Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-033287
Filing Date
2021-03-08
Accepted
2021-03-08 16:26:50
Documents
2
Period of Report
2021-03-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm218923-1_4.html 4  
1 OWNERSHIP DOCUMENT tm218923-1_4.xml 4 6150
2 EXHIBIT 24 tm218923d1_ex24.htm EX-24 8700
  Complete submission text file 0001104659-21-033287.txt   16665
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SELLAS LIFE SCIENCES GROUP, INC. 2000 CROW CANYON PLACE, SUITE 380 SAN RAMON CA 94583
Business Address
Stergiou Angelos M. (Reporting) CIK: 0001724253 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 21722304